Search
01/11/2024
Understanding Endothelial Dysfunction and Its Role in Ischemic Stroke After the Outbreak of Recanalization Therapies
de la Riva, P, Marta-Enguita, J, Rodríguez-Antigueedad, J, Bergareche, A, de Munain, AL. Understanding Endothelial Dysfunction and Its Role in Ischemic Stroke After the Outbreak of Recanalization Therapies. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(21)DOI:10.3390/ijms252111631. PMID:39519182. IF:4.900(Q1/3D).
01/10/2024
Small RNAs in plasma extracellular vesicles define biomarkers of premanifest changes in Huntington's disease
Herrero-Lorenzo, M, Pérez-Pérez, J, Escaramís, G, Martínez-Horta, S, Pérez-González, R, Rivas-Asensio, E, Kulisevsky, J, Gámez-Valero, A, Martí, E. Small RNAs in plasma extracellular vesicles define biomarkers of premanifest changes in Huntington's disease. Journal of Extracellular Vesicles. 2024; 13(10)DOI:10.1002/jev2.12522. PMID:39377487. IF:14.500(Q1/1D).
28/08/2024
Skin Tau Quantification as a Novel Biomarker in Huntington's Disease
Ruiz-Barrio, I, Vázquez-Oliver, A, Puig-Davi, A, Rivas-Asensio, E, Perez-Perez, J, Fernandez-Vizuete, C, Horta-Barba, A, Olmedo-Saura, G, Salvat-Rovira, N, Sampedro, F, Vacchi, E, Melli, G, Pagonabarraga, J, Kulisevsky, J, Martinez-Horta, S. Skin Tau Quantification as a Novel Biomarker in Huntington's Disease. MOVEMENT DISORDERS. 2024; 39(11)DOI:10.1002/mds.29989. PMID:39192729. IF:7.600(Q1/1D).
10/08/2024
Impact of Stimulation Frequency on Verbal Fluency Following Bilateral Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
Busteed, L, García-Sánchez, C, Pascual-Sedano, B, Grunden, N, Gironell, A, Kulisevsky, J, Pagonabarraga, J. Impact of Stimulation Frequency on Verbal Fluency Following Bilateral Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY. 2024; DOI:10.1093/arclin/acae062. PMID:39127889. IF:2.100(Q2/5D).
05/08/2024
Prediction of Cognitive Heterogeneity in Parkinson's Disease: A 4-Year Longitudinal Study Using Clinical, Neuroimaging, Biological and Electrophysiological Biomarkers
Puig-Davi, A, Martinez-Horta, S, Pérez-Carasol, L, Horta-Barba, A, Ruiz-Barrio, I, Aracil-Bolaños, I, Pérez-González, R, Rivas-Asensio, E, Sampedro, F, Campolongo, A, Pagonabarraga, J, Kulisevsky, J. Prediction of Cognitive Heterogeneity in Parkinson's Disease: A 4-Year Longitudinal Study Using Clinical, Neuroimaging, Biological and Electrophysiological Biomarkers. ANNALS OF NEUROLOGY. 2024; 96(5)DOI:10.1002/ana.27035. PMID:39099459. IF:7.700(Q1/1D).
01/07/2024
Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study
Santos-Garcia, D, de Deus, T, Cores, C, Painceiras, MJF, Alvarado, MCI, Samaniego, LB, Maside, AL, Jesus, S, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Hernandez-Vara, J, Lopez, IC, Manzanares, LL, Gonzalez-Aramburu, I, Avila, A, Gomez-Mayordomo, V, Nogueira, V, Garcia-Soto, JD, Borrue-Fernandez, C, Solano, B, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Mendoza, Z, Parees, I, Alonso, PS, Losada, MGA, Lopez-Ariztegui, N, Gaston, I, Kulisevsky, J, Seijo, M, Valero, C, Redondo, RA, Buongiorno, MT, Ordas, C, Menendez-Gonzalez, M, Mcafee, D, Martinez-Martin, P, Mir, P. Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study. Movement Disorders Clinical Practice. 2024; 11(7)DOI:10.1002/mdc3.14056. PMID:38747234. IF:2.700(Q2/5D).
28/06/2024
Essential Tremor: Update of Therapeutic Strategies
Gironell, A, Marín-Lahoz, J, Póveda, S. Essential Tremor: Update of Therapeutic Strategies. MEDICINA CLINICA. 2024; 162(12)DOI:10.1016/j.medcli.2023.12.013. PMID:38553256. IF:2.100(Q2/3D).
15/06/2024
Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies
Dellarole, IL, Vacchi, E, Ruiz-Barrio, I, Pinton, S, Raimondi, A, Rossi, S, Morandi, S, Bianco, G, Bacinoglu, MB, Lombardo, A, Celauro, L, Staedler, C, Galati, S, Pagonabarraga, J, Kulisevsky, J, Legname, G, Gobbi, C, Kaelin-Lang, A, Moda, F, Melli, G. Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies. npj Parkinsons Disease. 2024; 10(1)DOI:10.1038/s41531-024-00728-9. PMID:38879633. IF:8.200(Q1/1D).